Increase of intracellular methylglyoxal levels as a mode of action of retinoids against psoriasis.
Namazi
M R
MR
D000284:Administration, Oral; D015415:Biomarkers / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy*; D011765:Pyruvaldehyde / Q000378:metabolism*; D012176:Retinoids / Q000008:administration & dosage*; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D015415:Biomarkers; D012176:Retinoids; D011765:Pyruvaldehyde